These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28668112)

  • 21. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
    Neven B; Magerus-Chatinet A; Florkin B; Gobert D; Lambotte O; De Somer L; Lanzarotti N; Stolzenberg MC; Bader-Meunier B; Aladjidi N; Chantrain C; Bertrand Y; Jeziorski E; Leverger G; Michel G; Suarez F; Oksenhendler E; Hermine O; Blanche S; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2011 Nov; 118(18):4798-807. PubMed ID: 21885602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder.
    Jeffreys SM; Levy RA; Crary SE
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e305-e308. PubMed ID: 28991130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
    López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
    Front Immunol; 2021; 12():671755. PubMed ID: 34447369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do T cells cause so much trouble?
    McClain KL
    Blood; 2014 Mar; 123(13):1978. PubMed ID: 24677399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
    Caminha I; Fleisher TA; Hornung RL; Dale JK; Niemela JE; Price S; Davis J; Perkins K; Dowdell KC; Brown MR; Rao VK; Oliveira JB
    J Allergy Clin Immunol; 2010 Apr; 125(4):946-949.e6. PubMed ID: 20227752
    [No Abstract]   [Full Text] [Related]  

  • 27. [Autoimmune lymphoproliferative syndrome: a case report].
    Ruan YS; He YL; Feng XQ
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):309-10. PubMed ID: 23927808
    [No Abstract]   [Full Text] [Related]  

  • 28. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation.
    Hauck F; Magerus-Chatinet A; Vicca S; Rensing-Ehl A; Roesen-Wolff A; Roesler J; Rieux-Laucat F
    Clin Immunol; 2013 Apr; 147(1):61-68. PubMed ID: 23524443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS).
    Tessarin G; Mazza C; Baronio M; Gazzurelli L; Rossi S; Moratto D; Badolato R; Rensing-Ehl A; Ehl S; Warnatz K; Rosanelli C; Morello E; Plebani A; Lougaris V
    Clin Immunol; 2021 Jul; 228():108757. PubMed ID: 33992756
    [No Abstract]   [Full Text] [Related]  

  • 30. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
    Teachey DT
    Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].
    Garrido Colino C
    An Pediatr (Barc); 2014 Feb; 80(2):122.e1-7. PubMed ID: 24055319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.
    Lo B; Ramaswamy M; Davis J; Price S; Rao VK; Siegel RM; Lenardo MJ
    J Clin Immunol; 2013 Feb; 33(2):479-88. PubMed ID: 23054345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.
    Nabhani S; Hönscheid A; Oommen PT; Fleckenstein B; Schaper J; Kuhlen M; Laws HJ; Borkhardt A; Fischer U
    Clin Immunol; 2014 Dec; 155(2):231-7. PubMed ID: 25451160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of autoimmune lymphoproliferactive syndrome and literature review].
    Liu L; Hu J; Ma J; Li X; Li F; Li C
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
    Takagi M; Shinoda K; Piao J; Mitsuiki N; Takagi M; Matsuda K; Muramatsu H; Doisaki S; Nagasawa M; Morio T; Kasahara Y; Koike K; Kojima S; Takao A; Mizutani S
    Blood; 2011 Mar; 117(10):2887-90. PubMed ID: 21063026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Seif AE; Grupp SA
    Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance.
    Turbyville JC; Rao VK
    Autoimmun Rev; 2010 May; 9(7):488-93. PubMed ID: 20170754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
    Li P; Huang P; Yang Y; Hao M; Peng H; Li F
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunological analysis of a large kindred affected by autoimmune lymphoproliferative syndrome (ALPS) due to a novel TNFRSF6 mutation displaying age dependent disease activity.
    Tessarin G; Baronio M; Gazzurelli L; Rossi S; Gorio C; Bertoni E; Chiarini M; Moratto D; Mazza C; Porta F; Badolato R; Lougaris V
    Clin Immunol; 2022 Dec; 245():109136. PubMed ID: 36184054
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.
    Xie Y; Pittaluga S; Price S; Raffeld M; Hahn J; Jaffe ES; Rao VK; Maric I
    Haematologica; 2017 Feb; 102(2):364-372. PubMed ID: 27846610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.